Objective: As their proportion rises in the aging population, cardiovascular disease and osteoporosis increasingly become significant health problems of the developed world, leading to reduced lifespan and substantial financial burdens, not the least because of complications and comorbidities associated with each disorder. This study investigates bone mineralization in patients with coronary heart disease (CHD) complicated by Stage I chronic heart failure (CHF).
INTRODUCTION
Although structural changes of the spine are primarily connected with aging, so-called diseases of civilization, which predominately include cardiovascular system disorders, increase the pace of osteopathic changes [1] . The prevalence of cardiovascular diseases (CVD) is a global health problem that leads to impaired quality of life and shortens life expectancy [2] . CVD are the most frequent cause of morbidity and mortality not only in developed nations but also in developing nations [3] . CVD, as well as osteoporosis, are high-burden health issues due to their increased incidence with age and significant monetary costs needed for treatment of such patients [4] . Chronic heart failure (CHF) is a syndrome rather than a disease, the cause of which may be structural or functional, or more often than not, both. Whatever be the underlying cause, the cardinal symptoms are dyspnea and fatigue leading to a progressive decrease in exercise capacity [5] . It should be noted that CHF and osteoporosis are often diagnosed in the same patient [6] . The majority of the studies have shown that individuals with CVD have a higher risk of experiencing bone loss and thus greater predisposition to the risk of fracture. On the other hand, there is growing evidence that individuals with low bone mass have a higher mortality for cardiovascular events compared to patients with CVD with normal bone mass [7] . Recent recommendations suggest that elderly patients with low bone mineral density (BMD) require thorough evaluation for possible CVD [8] . Likewise, another study recommends taking into account the possibility of CVD in elderly patients being treated for osteoporosis [9] . Since the treatment of osteoporosis and its complications is a difficult, timeconsuming and not always effective process, currently the predominant approach in dealing with this disease is prevention.
Objectives
This study aims to investigate bone mineralization in patients with coronary heart disease (CHD) complicated by Stage I CHF.
METHODS
The study involved 41 patients of both sexes aged from 40 to 70 years with Stage I CHF (according to the classification by Strazhesko, Vasilenko and Lung [1935] ) against the background of coronary artery disease. The patients did not have other severe comorbidities that could have caused changes in bone tissue. All study participants were hospitalized patients and had given written consent for their clinical data to be used in the study. All reported research conducted in accordance with the principles set forth in the Helsinki Declaration, 2008.
Diagnosis of coronary artery disease was confirmed using a set of characteristic anamnestic, clinical (typical angina attacks with physical and psycho-emotional stress), biochemical (increased total cholesterol and total lipids levels), and electrocardiography (STsegment depression below the baseline and T-wave inversion) data.
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To corroborate diagnosis, we also used data obtained during a physical examination, such as enlarged to the left heart boundaries, weakened sound of the top tone, stress of the second tone above the aorta, and changes in blood pressure and heart rate.
To verify the diagnosis of heart failure, we used main limiting factors of physical performance and clinical symptoms: Dyspnea, tachycardia, and fatigue after exertion. The final diagnosis of CHF with systolic dysfunction was given based on the results of echocardiography test.
Among the patients included in the study, 23 (56.1%) were men and 18 (43.9%) women. The average age of men was 56.05±1.68 years. While their body mass index (BMI) exceeded normal range (set at <25 kg/m 2 ) and was in the range of uncompensated obesity, 28.25±0.80 kg/m 2 , it was not significantly different from BMI of research groups. The average age of women was 58.11±2.09 years, their BMI also exceeded that of the control group by 16% and was in the range of uncompensated obesity, 28.08±1.20 kg/m 2 . Clinical characteristics of the patients in the experimental group were as follows: The disease duration ranged from 2 to 5 years, the underlying disorders mainly were postmyocardial infarction cardiosclerosis and stable angina.
During the initial assessment, we found no significant statistical differences anthropometric characteristics such as age, BMI, and length of the between male and female patients, thus for the purposes of subsequent statistical analysis, we directly compared these two groups.
DXA is widely used for measuring BMD because of its recognized precision [10] . The method utilizes two measurements, T-score and Z-score. The first one is calculated when the patient's BMD is subtracted from mean BMD of a population of healthy young adults, matched. The T-score is calculated as a number of SDs the patient's measured BMD is above or below the mean for the population of healthy 30-year adults, matched for sex and ethnicity. The Z-score is expressed in units of the population SD, but instead of comparing the patient's BMD to the mean of the young adult population, it is compared with the mean BMD of a healthy population matched for age, sex, and ethnicity. In this study, we evaluated the scores according to the WHO guidelines (WHO, Geneva, 1994): BMD >1.2 g/sm 2 is classified as osteosclerosis; a T-score ≥ −1 is regarded as normal and T-score between −2.5 and −1 is classified as osteopenia [11] .
The control population samples were selected from a densitometric database of healthy individuals maintained at the medical diagnostic center of Ternopil State Medical University and designated as young adults and age-matched groups [12, 13] .
The results were analyzed using Statistica 7.0 software and presented as mean with standard deviations. To evaluate the distribution of the character together by sampling data, we have used Lilliefors and Kolmogorov -Smirnov tests. The differences between all groups were determined using one-way ANOVA, followed by post hoc least significant difference test. p<0.05 was considered statistically significant.
RESULTS
Densitometry analysis of lumbar segment in the second group of patients with Stage I CHF showed that in men normal BMD was (Tables 1-3) . It should be noted that in females diagnosed with osteopenia the indicators of BMD were significantly lower than in men at L 1 and L 2 , whereas in patients with increased mineralization BMD changed in the same way in both sexes in all studied vertebrae (Table 1) .
A comparative analysis of indicators of the detected peak BMD to that in young healthy subjects in Table 2 shows that compared with men, in women with osteopenia the mineral content reduction in the first two lumbar vertebrae is more pronounced, while BMD is significantly increased in cases of osteosclerosis at L 4 . Because we found no CHF Stage I female patients with preserved BMD, it was not possible to compare male and female BMD indicators in this group.
Age-matched BMD measurements (% departure and Z-score) in men diagnosed with osteopenia do not differ from their BMD scores relative to young healthy adults (p>0.05), while in women scores calculated in relation to the age-matched were higher than the ones to young adult: At L 1 by 1.67 times; L2 by 1.96 times; L3 by 1.46 times; and L 4 by 1.68 times.
BMD data of the right proximal femur (Table 4) show a large number of osteopenia cases (61.8%) compared to those of preserved BMD (38.2%), indicating more pronounced changes of thigh bone tissue as opposed to the lumbar spine. Densitograms of the patients with low mineralization show in 100% of the cases osteopenia in Ward's triangle (Δ), in 30.77% of the cases osteopenia of the femoral neck, and in 7.69% of the cases general osteopenia. In men, we diagnosed no bone changes in the greater trochanter. Assessing the osteopenic syndrome, we found significantly lower (p<0.05) rates of BMD relative to the young adult group (% departure and T-score) in all surveyed areas compared with normal bone tissue in male patients with CHF Stage I. The indicators of bone tissue mineralization of the same patients relative to the agematched group (% departure and Z-score) were also lower (p<0.05) in the femoral neck, Δ Ward section and the proximal femur.
Comparative analysis of the structural and functional condition of the hip bone in female patients with CHF Stage I show the prevalence of bone demineralization. Various degrees of osteopenia were found in 61% of the patients, while 39% exhibited preserved BMD. When compared to the young adult reference group, right femur BMD values in these women show bone density decrease in the femoral neck, Ward's triangle and the greater trochanter as measured by both % departure and T-score. At the same time, the ratio of the female patients' BMD to that of the age-matched group was significantly higher than the ratio of the patients' BMD to the young adult group (Table 5) .
Given the large number of patients with CHF Stage I diagnosed with osteoporosis of proximal femur, we analyzed the extent of osteopenia. Among the 24 patients, Stage 1 osteoporosis was diagnosed: In the neck, , and the T-score was (−2.28±0.09). The results indicate that in men with CHF Stage I osteopenia syndrome is more often diagnosed in the proximal right femur, while in women it is diagnosed almost equally often in the spine and hip.
DISCUSSION
Studies point to the connection of CVD with decreased BMD [14, 15] . CVD and osteoporosis are major causes of morbidity, mortality, and disability.
Myocardium's ability to contract is an important factor determining adequate blood circulation in organs and tissues. Isotropic function of the heart depends on the interaction of cytosol calcium with contractile proteins. Increased interaction may be due to increasing calcium levels in cardiomyocytes during the systole or increased sensitivity of the protein structures to calcium [16] . In this study, we aimed to show the relationship of CHF with pathological changes in bone tissue that are generally not caused by the usual risk factors.
There are well-characterized biochemical changes observed during CHF, including reduced activity of enzymes that regulate calcium homeostasis; inhibited calcium ATPase in the sarcoplasmic reticulum; and increased activity of sarcolemmal sodium-calcium exchange [17] . These changes are accompanied by shifts in calcium homeostasis, with decreased diastolic capture of calcium in the sarcoplasmic reticulum, followed by decrease in calcium release during the next systole, resulting in hypercontractivity of the myocardium. Results of this study suggest that during CHF advance the levels of calcium and phosphorus in the blood may be supported at the expense of the destruction of the bone tissue, which, in some cases, can initiate development of osteoporosis. Therefore, we believe that CVD is one of the factors that reduce BMD, while bone demineralization, in turn, complicates the course of CHF pathology.
As a result, structural and functional changes in the bone tissue of the lumbar spine were found in 75.9% of patients with Stage 1 of CHF caused by ischemic heart disease: 64.4% of patients had osteopenic syndrome, and the rest, 11.5%, osteosclerotic changes. In 75.8% of CHF patients, we found structural and functional changes in the bone tissue of proximal right femur. In men with CHF Stage I against the background of CHD, osteopenic syndrome was more often diagnosed in the proximal right femur, while in women in almost equal measure in the spine and hip.
ACKNOWLEDGMENTS
The author is grateful to PhD Inna Birchenko for revision of the English text.
AUTHORS CONTRIBUTION
Conception, design, data analysis and interpretation, manuscript draft and critical review, final approval of the manuscript.
